Abstract
This paper presents the results of the literature review conducted for the working group topic on inflammation, infection, exposure, and the human microbiome. Infection and chronic inflammation can elevate risk for cardiovascular disease and cancer. Environmental exposures common among South Asian (SA) subgroups, such as arsenic exposure among Bangladeshis and particulate matter air pollution among taxi drivers, also pose risks. This review explores the effects of exposure to arsenic and particulate matter, as well as other infections common among SAs, including human papillomavirus (HPV) and hepatitis B/C infection. Emerging research on the human microbiome, and the effect of microbiome changes on obesity and diabetes risk among SAs are also explored.
Similar content being viewed by others
References
Smedley PL, Kinniburgh DG. A review of the source, behaviour and distribution of arsenic in natural waters. Appl Geochem. 2002;17(5):517–68.
McCarty KM, Hanh HT, Kim KW. Arsenic geochemistry and human health in South East Asia. Rev Environ Health. 2011;26(1):71–8.
Smith AH, Lingas EO, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000;78(9):1093–103.
Dhar RK, Biswas BK, Samanta G, Mandal BK, Chakraborti D, Roy S, Jafar A, Islam A, Ara G, Kabir S, Quamruzzaman Q, Chakraborti D. Groundwater arsenic calamity in Bangladesh. Curr Sci. 1997;73(1):48–59.
Roychowdhury T. Impact of sedimentary arsenic through irrigated groundwater on soil, plant, crops and human continuum from Bengal delta: Special reference to raw and cooked rice. Food Chem Toxicol. 2008;46(8):2856–64.
Chen Y, Ahsan H. Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health. 2004;94(5):741–4.
Halder D, Bhowmick S, Biswas A, Mandal U, Nriagu J, Mazumdar DN, Chatterjee D, Bhattacharya P. Consumption of brown rice: a potential pathway for arsenic exposure in rural Bengal. Environ Sci Technol. 2012;46(7):4142–8.
Davis MA, Signes-Pastor AJ, Argos M, Slaughter F, Pendergrast C, Punshon T, Gossai A, Ahsan H, Karagas MR. Assessment of human dietary exposure to arsenic through rice. Sci Total Environ. 2017;586:1237–44.
U.S. Food and Drug Administration: FDA releases preliminary data on arsenic levels in rice and rice products. 2012.
Consumer Reports: Arsenic in your food: Our findings show a real need for federal standard for this toxin. November 2012 April 2014]; Available from: http://consumerreports.org/cro/magazine/2012/11/arsenic-in-your-food/index.htm.
Argos M, Kalra T, Rathouz PJ, Chen Y, Pierce B, Parvez F, Islam T, Ahmed A, Rakibuz-Zaman M, Hasan R, Sarwar G, Slavkovich V, van Geen A, Graziano J, Ahsan H. Arsenic exposure from drinking water, and all-cause and chronic-disease mortalities in Bangladesh (HEALS): a prospective cohort study. Lancet. 2010;376(9737):252–8.
Argos M, Kalra T, Pierce BL, Chen Y, Parvez F, Islam T, Ahmed A, Hasan R, Hasan K, Sarwar G, Levy D, Slavkovich V, Graziano JH, Rathouz PJ, Ahsan H. A prospective study of arsenic exposure from drinking water and incidence of skin lesions in Bangladesh. Am J Epidemiol. 2011;174(2):185–94.
Ruiz de Luzuriaga AM, Ahsan H, Shea CR. Arsenical keratoses in Bangladesh–update and prevention strategies. Dermatol Clin. 2011;29(1):45–51.
Guha Mazumder DN. Arsenic and non-malignant lung disease. J Environ Sci Health A. 2007;42(12):1859–67.
Martinez VD, Vucic EA, Becker-Santos DD, Gil L, Lam WL. Arsenic exposure and the induction of human cancers. J Toxicol. 2011;2011:431287.
Huang YK, Huang YL, Hsueh YM, Yang MH, Wu MM, Chen SY, Hsu LI, Chen CJ. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control. 2008;19(8):829–39.
Moon K, Guallar E, Navas-Acien A. Arsenic exposure and cardiovascular disease: an updated systematic review. Curr Atheroscler Rep. 2012;14(6):542–55.
Das N, Paul S, Chatterjee D, Banerjee N, Majumder NS, Sarma N, Sau TJ, Basu S, Banerjee S, Majumder P, Bandyopadhyay AK, States JC, Giri AK. Arsenic exposure through drinking water increases the risk of liver and cardiovascular diseases in the population of West Bengal, India. BMC Public Health. 2012;12:639.
Lewis DR, Southwick JW, Quellet-Hellstrom R, Rench J, Calderon RL. Drinking water arsenic in Utah: a cohort mortality study. Environ Health Perspect. 1999;107(5):359–65.
Benowitz NL. Cardiotoxicity in the workplace. Occup Med. 1992;7(3):465–78.
Goldsmith S, From AH. Arsenic-induced atypical ventricular tachycardia. N Engl J Med. 1980;303(19):1096–8.
Ratnaike RN. Acute and chronic arsenic toxicity. Postgrad Med J. 2003;79(933):391–6.
Pieters N, Plusquin M, Cox B, Kicinski M, Vangronsveld J, Nawrot TS. An epidemiological appraisal of the association between heart rate variability and particulate air pollution: a meta-analysis. Heart. 2012;98(15):1127–35.
United States Environmental Protection Agency: Particulate Matter. 2 April 2013 31 March 2014]; Available from: http://www.epa.gov/airscience/air-particulatematter.htm.
Brook RD, Rajagopalan S, Pope CA III, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, Peters A, Siscovick D, Smith SC Jr, Whitsel L, Kaufman JD. Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association. Circulation. 2010;121(21):2331–78.
Cavallari JM, Eisen EA, Chen JC, Fang SC, Dobson CB, Schwartz J, Christiani DC. Night heart rate variability and particulate exposures among boilermaker construction workers. Environ Health Persp. 2007;115(7):1046–51.
Cavallari JM, Fang SC, Eisen EA, Schwartz J, Hauser R, Herrick RF, Christiani DC. Time course of heart rate variability decline following particulate matter exposures in an occupational cohort. Inhal Toxicol. 2008;20(4):415–22.
Chuang KJ, Chan CC, Su TC, Lee CT, Tang CS. The effect of urban air pollution on inflammation, oxidative stress, coagulation, and autonomic dysfunction in young adults. Am J Respir Crit Care Med. 2007;176(4):370–6.
Fang SC, Cassidy A, Christiani DC. A systematic review of occupational exposure to particulate matter and cardiovascular disease. Int J Env Res Public Health. 2010;7(4):1773–806.
Magari SR, Hauser R, Schwartz J, Williams PL, Smith TJ, Christiani DC. Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation. 2001;104(9):986–91.
Wu S, Deng F, Niu J, Huang Q, Liu Y, Guo X. Association of heart rate variability in taxi drivers with marked changes in particulate air pollution in Beijing in 2008. Environ Health Perspect. 2010;118(1):87–91.
Wu SW, Deng FR, Niu J, Huang QS, Liu YC, Guo XB. The relationship between traffic-related air pollutants and cardiac autonomic function in a panel of healthy adults: a further analysis with existing data. Inhal Toxicol. 2011;23(5):289–303.
Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC Jr, Tager I. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 2004;109(21):2655–71.
Min KB, Min JY, Cho SI, Paek D. The relationship between air pollutants and heart-rate variability among community residents in Korea. Inhal Toxicol. 2008;20(4):435–44.
Riediker M, Devlin RB, Griggs TR, Herbst MC, Bromberg PA, Williams RW, Cascio WE. Cardiovascular effects in patrol officers are associated with fine particulate matter from brake wear and engine emissions. Part Fibre Toxicol. 2004;1(1):2.
Weichenthal S, Kulka R, Dubeau A, Martin C, Wang D, Dales R. Traffic-related air pollution and acute changes in heart rate variability and respiratory function in urban cyclists. Environ Health Perspect. 2011;119(10):1373–8.
Dockery DW, Pope CA, Xu XP, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE. An Association between Air-Pollution and Mortality in 6 United-States Cities. N England J Med. 1993;329(24):1753–9.
Pope CA III, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. Lung cancer cardiopulmonary mortality and long-term exposure to fine particulate air pollution. J Am Med Assoc. 2002;287:1132–41.
Pope CA 3rd, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Heath CW Jr. Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med. 1995;151(3 Pt 1):669–74.
Gallus S, Negri E, Boffetta P, McLaughlin JK, Bosetti C, La Vecchia C. European studies on long-term exposure to ambient particulate matter and lung cancer. Eur J Cancer Prev. 2008;17(3):191–4.
Lepeule J, Laden F, Dockery D, Schwartz J. Chronic exposure to fine particles and mortality: an extended follow-up of the harvard six cities study from 1974 to 2009. Environ Health Perspect. 2012;120:965
Turner MC, Krewski D, Pope CA 3rd, Chen Y, Gapstur SM, Thun MJ. Long-term ambient fine particulate matter air pollution and lung cancer in a large cohort of never-smokers. Am J Respir Crit Care Med. 2011;184(12):1374–81.
Smith KR. National burden of disease in India from indoor air pollution. PNAS. 2000;97(24):13286–93.
Gany F, Bari S, Prasad L, Leng J, Lee T, Thurston G, Gordon T, Rexford B, Zelikoff J. Perception and reality of particulate matter (PM) exposure in New York City taxi drivers. Am J Public Health 2013;27:221. [In Preparation].
Schaller Consulting: The changing face of taxi and limousine drivers: U.S., large states and metro areas and New York City. Brooklyn: Schaller Consulting; 2004
Blasi G, Leavitt J. Driving poor: taxi drivers and the regulation of the taxi industry in Los Angeles. Los Angeles: UCLA Institute of Industrial Relations; 2006.
Waheed S, Romero-Alston L. UNFARE taxi drivers and the cost of moving the city. 2003.
Gany FM, Gill PP, Ahmed A, Acharya S, Leng J. Every disease… man can get can start in this cab: focus groups to identify South Asian taxi drivers’ knowledge, attitudes and beliefs about cardiovascular disease and its risks. J Immigr Minor Health. 2013;15(5):986–92.
Apantaku-Onayemi F, Baldyga W, Amuwo S, Adefuye A, Mason T, Mitchell R, Blumenthal DS. Driving to better health: cancer and cardiovascular risk assessment among taxi cab operators in Chicago. J Health Care Poor Underserved. 2012;23(2):768–80.
Reiss K, Lehnhardt J, Razum O. Factors associated with smoking in immigrants from non-western to western countries—what role does acculturation play? A systematic review. Tob Induc Dis. 2015;13(1):11.
Hansen J, Raaschou-Nielsen O, Olsen JH. Increased risk of lung cancer among different types of professional drivers in Denmark. Occup Environ Med. 1998;55(2):115–8.
Jakobsson R, Gustavsson P, Lundberg I. Increased risk of lung cancer among male professional drivers in urban but not rural areas of Sweden. Occup Environ Med. 1997;54(3):189–93.
Guberan E, Usel M, Raymond L, Bolay J, Fioretta G, Puissant J. Increased Risk for lung-cancer and for cancer of the gastrointestinal-tract among geneva professional drivers. Brit J Ind Med. 1992;49(5):337–44.
Arbyn M, Castellsague X, de Sanjose S, Bruni L, Saraiya M, Bray F, Ferlay J. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22(12):2675–86.
Munoz N, Bosch FX, Castellsague X, Diaz M, De Sanjose S, Hammouda D, Shah KV, Meijer C. Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer. 2004;111(2):278–85.
cdc: hpv.
Franceschi S, Bidoli E, Herrero R, Munoz N. Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol. 2000;36(1):106–15.
Schwartz SM DJ, Doody DR, Wipf GC, Carter JJ, Madeleine MM, et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst. 1998;90:1626–636
McCaffery K, Forrest S, Waller J, Desai M, Szarewski A, Wardle J. Attitudes towards HPV testing: a qualitative study of beliefs among Indian, Pakistani, African-Caribbean and white British women in the UK. Br J Cancer. 2003;88(1):42–6.
Szarewski A, Cadman L, Ashdown-Barr L, Waller J. Exploring the acceptability of two self-sampling devices for human papillomavirus testing in the cervical screening context: a qualitative study of Muslim women in London. J Med Screen. 2009;16(4):193–8.
Cohen C, Caballero J, Martin M, Weerasinghe I, Ninde M, Block J. Eradication of hepatitis B: A nationwide community coalition approach to improving vaccination, screening, and linkage to care. J Commun Health. 2013;38:799–804
Hu KQ, Pan CQ, Goodwin D. Barriers to screening for hepatitis B virus infection in Asian Americans. Dig Dis Sci. 2011;56(11):3163–71.
Wasley A, Kruszon-Moran D, Kuhnert W, Simard EP, Finelli L, McQuillan G. The prevalence of hepatitis B virus infection in the united states in the era of vaccination. J Infect Dis. 2010;202(2):192–201.
Adams KM, Gardiner LD, Assefi N. Healthcare challenges from the developing world: post-immigration refugee medicine. BMJ. 2004;328(7455):1548–52.
Hahne S, Ramsay M, Soldan K, Balogun K, Mortimer P. Hepatitis B incidence among South Asian children in England and Wales: implications for immunisation policy. Arch Dis Child. 2003;88(12):1082–3.
Tong MJ, Pan CQ, Hann HW, Kowdley KV, Han SH, Min AD, Leduc TS. The management of chronic hepatitis B in Asian Americans. Dig Dis Sci. 2011;56(11):3143–62.
Nguyen LH, Nguyen MH. Systematic review: Asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther. 2013;37(10):921–36.
Averhoff FM, Glass N, Holtzman D. Global burden of hepatitis C: considerations for healthcare providers in the United States. Clin Infect Dis. 2012;55:S10-S15.
Fabrizi F, Messa P, Martin P. Transmission of hepatitis C virus infection in hemodialysis: current concepts. Int J Artif Organs. 2008;31(12):1004–16.
Kosaraju K, Faujdar SS, Singh A, Prabhu R. Hepatitis viruses in heamodialysis patients: an added insult to injury?. Hepat Res Treat 2013; 2013:860514.
Bhattacharya S, Price N, Boxall E, Adu D, Lipkin G, Smith S, Osman H. Holiday haemodialysis and imported hepatitis C virus infection: A series of sixteen cases in two large haemodialysis units. J Clin Virol. 2009;45(4):296–9.
Jafferbhoy H, Miller MH, McIntyre P, Dillon JF. The effectiveness of outreach testing for hepatitis C in an immigrant Pakistani population. Epidemiol Infect. 2012;140(6):1048–53.
Perumalswami PV, Factor SH, Kapelusznik L, Friedman SL, Pan CQ, Chang C, Di Clemente F, Dieterich DT. Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities. J Hepatol. 2013;58(5):890–7.
Blaser MJ. Who are we? Indigenous microbes and the ecology of human disease. Eur Mol Biol Organ 2006;7(10): 956.
Croucher R, Dahiya M, Gowda KK. Contents and price of vendor assembled paan quid with tobacco in five London localities: a cross-sectional study. Tob Control. 2013;22(2):141–3.
Sommer F, Backhed F. The gut microbiota—masters of host development and physiology. Nat Rev Microbiol. 2013;11(4):227–38.
Blaser MJ, Falkow S. What are the consequences of the disappearing human microbiota? Nat Rev Microbiol. 2009;7(12):887–94.
US Taxi and Limo Drivers Now Eligible for Group Health Benefits.
Zhu Q, Gao R, Wu W, Qin H. The role of gut microbiota in the pathogenesis of colorectal cancer. Tumour Biol. 2013;34(3):1285–300.
Graham DY, Lu H, Yamaoka Y. African, Asian or Indian enigma, the East Asian helicobacter pylori: facts or medical myths. J Dig Dis. 2009;10(2):77–84.
Khan AA, Shrivastava A, Khurshid M. Normal to cancer microbiome transformation and its implication in cancer diagnosis. Biochim Biophys Acta. 2012;1826(2):331–7.
Ahn J, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Control. 2012;23(3):399–404.
Huang YJ, Charlson ES, Collman RG, Colombini-Hatch S, Martinez FD, Senior RM. The role of the lung microbiome in health and disease. A national heart, lung, and blood institute workshop report. Am J Respir Crit Care Med. 2013;187(12):1382–7.
Jobin C. Colorectal cancer: looking for answers in the microbiota. Cancer Discov. 2013;3(4):384–7.
Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE. 2012;7(6):e39743.
Sobhani I, Amiot A, Le Baleur Y, Levy M, Auriault ML, Van Nhieu JT, Delchier JC. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease?. Therap Adv Gastroenterol 2013; 6(3).
den Hollander WJ, Holster IL, den Hoed CM, van Deurzen F, van Vuuren AJ, Jaddoe VW, Hofman A, Perez-Perez GI, Blaser MJ, Moll HA, Kuipers EJ. Ethnicity is a strong predictor for Helicobacter pylori infection in young women in a multi-ethnic European city. J Gastroenterol Hepatol. 2013;28(11):1705–11.
Perez-Perez GI, Olivares AZ, Foo FY, Foo S, Neusy AJ, Ng C, Holzman RS, Marmor M, Blaser MJ. Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia. J Urban Health. 2005;82(3):510–6.
Matsuhisa T, Aftab H. Observation of gastric mucosa in Bangladesh, the country with the lowest incidence of gastric cancer, and Japan, the country with the highest incidence. Helicobacter. 2012;17(5):396–401.
Miwa H, Go MF, Sato N. H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol. 2002;97(5):1106–12.
Bindels LB, Porporato P, Dewulf EM, Verrax J, Neyrinck AM, Martin JC, Scott KP, Buc Calderon P, Feron O, Muccioli GG, Sonveaux P, Cani PD, Delzenne NM. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br J Cancer. 2012;107(8):1337–44.
Ou J, Carbonero F, Zoetendal EG, Delany JP, Wang M, Newton K, Gaskins HR, O’Keefe SJ. Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr. 2013;98(1):111–20.
Everard A, Cani PD. Diabetes, obesity and gut microbiota. Best Pract Res Clin Gastroenterol. 2013;27(1):73–83.
Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev. 2010;31(6):817–44.
Wiedermann CJ, Kiechl S, Dunzendorfer S, Schratzberger P, Egger G, Oberhoolenzer F, Willeit J. Association ofendotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study. J Am Coll Cardiol. 1999;34:1975–81.
Miller M, McTernan PG, Harte AL, Silva NF, Strazzullo P, Alberti KG, Kumar S, Cappuccio. FP Ethnic and sex differences in circulating endotoxin levels: a novel marker of atherosclerotic and cardiovascular risk in a British multi-ethnic population. Atherosclerosis. 2009;203(2):494–502.
Tang WH, Wang Z, Levison BS, Koeth RA, Britt EB, Fu X, Wu Y, Hazen SL. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N Engl J Med. 2013;368(17):1575–84.
Acknowledgements
This publication was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number R13 MD007147- 01A1 and National Cancer Institute of the National Institutes of Health under Award Number P30 CA008748. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. SAHI staff would like to thank the Steering Committee members, all working group co-chairs, the Memorial Sloan Kettering Cancer Center Library, Rohini Rau-Murthy and the SAHI interns for their assistance in assembling this document.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Research Involving Human and Animal Rights
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Leng, J., Peruluswami, P., Bari, S. et al. South Asian Health: Inflammation, Infection, Exposure, and the Human Microbiome. J Immigrant Minority Health 21 (Suppl 1), 26–36 (2019). https://doi.org/10.1007/s10903-017-0652-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10903-017-0652-y